Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease

Neuroreport
A VenneriAlison D Murray

Abstract

Twenty seven patients with mild AD were enrolled in a prospective open label controlled study of rivastigmine. Assessments included a range of neuropsychiatric and behavioural measures and rCBF using HMPAO SPECTat baseline, three and six months. Significant enhancement of frontal, parietal and temporal brain blood flow with related psychometric improvement was observed in twelve of the treated patients. A pattern of reduced rCBF and cognitive performance was observed in four unresponsive and eleven untreated patients. The results suggest that alterations in the clinical and cognitive status of patients receiving a cholinesterase inhibitor are paralleled by changes in rCBF. Longitudinal assessment with repeated imaging offers a method of better understanding the effects of cholinesterase inhibition on the AD brain.

References

Mar 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·R HunterG M Goodwin
Oct 22, 1998·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·S WarrenD Pavel
Mar 10, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·P T FrancisG K Wilcock
Mar 16, 2000·Nuclear Medicine Communications·R T StaffA Venneri
May 10, 2001·The International Journal of Neuropsychopharmacology·Jeffrey L. Cummings
May 26, 2001·Clinics in Geriatric Medicine·C DeCarli

❮ Previous
Next ❯

Citations

Jul 31, 2007·Advances in Therapy·Sevim Sureyya CerciSeyfi Arslan
Nov 12, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Alberto Pupi, Flavio Mariano Nobili
Jun 8, 2006·Journal of Neural Transmission·R CeravoloU Bonuccelli
May 25, 2005·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Alberto PupiSandro Sorbi
Jan 7, 2004·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Guido RodriguezFlavio Nobili
Apr 6, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·O AlmkvistA Nordberg
May 14, 2004·Brain : a Journal of Neurology·Andrew J SaykinRobert B Santulli
Mar 29, 2006·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Jurgen A H R Claassen, René W M M Jansen
Jun 11, 2004·Clinical Neuropharmacology·Roger M LaneNigel H Greig
Aug 21, 2004·Clinical Neuropharmacology·Roberto CeravoloLuigi Murri
Mar 16, 2007·Dementia and Geriatric Cognitive Disorders·Matthias W RiepeIbrahim Gunay
May 2, 2007·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Howard Chertkow, Sandra Black
Aug 30, 2008·Neuropsychiatric Disease and Treatment·William J McGeownAnnalena Venneri
May 8, 2002·International Journal of Geriatric Psychiatry
Jan 18, 2007·Expert Opinion on Therapeutic Targets·Ulrike HolzgrabeEva Kugelmann
Oct 17, 2012·The Journal of Physiology·J W HamnerJ Andrew Taylor
Jan 23, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Janusch BlautzikThomas Meindl
Jul 18, 2012·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Erol Başar, Bahar Güntekin
Jan 12, 2010·Behavioural Brain Research·Arenda H E A Van Beek, Jurgen A H R Claassen
Apr 21, 2007·Magnetic Resonance Imaging·Annalena Venneri
Apr 20, 2007·Magnetic Resonance Imaging·Michael F ShanksAnnalena Venneri
Oct 19, 2010·CNS Neuroscience & Therapeutics·Frederick A SchmittJason T Olin
Oct 16, 2010·Neuropathology and Applied Neurobiology·W R Brown, C R Thore
Oct 7, 2004·Journal of the Neurological Sciences·Makoto TanakaToru Kita
Mar 31, 2004·Journal of Cataract and Refractive Surgery·Hiroki TamuraHiromu K Mishima
Oct 3, 2006·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·G G YenerE Başar
Jun 30, 2006·Journal of the Neurological Sciences·Iracema LeroiLaura Marsh
Nov 23, 2005·Neurobiology of Aging·Gustavo C Román, Raj N Kalaria

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Flavio NobiliGuido Rodriguez
The International Journal of Neuropsychopharmacology
S G PotkinJ H Fallon
© 2022 Meta ULC. All rights reserved